Investment

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (7-11 September 2026) 

News round-up for 7-11 September 2026 by Megan Thomas, Content Team at DDW.  This week’s news roundup covers upcoming Drug Discovery Innovators & Investors (DDII) in-person events and forum updates, alongside the latest Phase II clinical data across coeliac disease, bronchiectasis and head and neck cancer. Read More

#News

#BioInnovation Institute #Drug discovery #Funding #Investment

BII allocates eight million euros to three drug discovery companies

Six promising companies will receive additional funding of €1.3 ($1.5) million each from BioInnovation Institute (BII) to help them bring their technologies and products closer to market.  The six companies – PanTarg, 3Sonic, Inia Biosciences, Yngvi Bio, Proxi Biotech and Sagava – have all previously received €0.5 million in funding… Read More

#Business & Investment #News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (31 August – 4 September 2026) 

News round-up for 31 August – 4 September 2026 by Megan Thomas, Content Team at DDW.  This week’s news roundup covers new developments in vaccines, drug approvals, cardiovascular therapies and cancer drug response, alongside DDW’s upcoming digital forum focused on the technologies, strategies and investment trends shaping… Read More

#News

#Cardiometabolic diseases #Financing #Investment #Revier Therapeutics

Revier launches into cardiometabolic disease market with €6m

Revier Therapeutics has closed a €6 ($6.9) million seed financing and the launch of its operations.   The company has established the first therapeutic approach to selectively target class IIa histone deacetylases (HDACs) for the treatment of cardiometabolic diseases.   The financing was led by the KHAN Technology Transfer Fund II, with… Read More

#Business & Investment #News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (17-21 August 2026) 

News round-up for 17-21 August by Megan Thomas, Content Team at DDW.  This week’s news roundup covers new therapeutic approaches moving towards or through clinical development, alongside advances in drug discovery and the investment landscape supporting biotech innovation. The top stories:  DDII Digital Forum:… Read More

#News

#Biotechnology #Cancer research #Clinical trials #Drug discovery #Investment

This week in Drug Discovery (10-14 August 2026) 

News round-up for 10-14 August by Diana Turner, Content Team at DDW.  This week’s news round-up highlights new discoveries in cancer research, including the first trial of a new type of immunotherapy, an immune cell finding that could transform cancer treatment, and a groundbreaking drug… Read More

#News

Investment concept
#Investment #Rare disease #Spruce Biosciences

Charities donate $5.5m to expand access to rare disease treatment

Cure Sanfilippo Foundation and the National MPS Society have agreed a combined $5.5 million strategic investment in Spruce Biosciences, which will go towards the Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) for Sanfilippo Syndrome Type B (or MPS IIIB) Expanded Access Program (EAP).  Samir Gharib, President and Chief Financial Officer of… Read More

#Business & Investment #News

Rare diseases
#FDA #Golden Triangle #Investment #Priority Review #Rare disease #SynaptixBio #UK pharma

Rare disease biotech investment grows but UK lags

Investment in rare disease biotechs has increased following renewal of the FDA’s Priority Review Voucher (PRV) programme, according to SynaptixBio, but the United States remains dominant compared to the UK. In February 2026, the PRV programme was signed into law and will remain in place until reviewed again in September… Read More

#News

#Biotechnology #Cancer research #Clinical trials #Drug discovery #Investment

This week in Drug Discovery (3-7 August 2026) 

News round-up for 3-7 August by Diana Turner, Content Team at DDW.  This week’s news round-up highlights new clinical trial results that demonstrate positive outcomes in Parkinson’s, colorectal cancer and Bundibugyo ebolavirus, as well as the first ever trial of a fridge-free vaccine. Elsewhere,… Read More

#News

#DDIIeventseries #DDIIUK2026 #Events #Investment

Registration now open for Drug Discovery Innovators & Investors UK Conference

The Drug Discovery Innovators & Investors (DDII) UK Conference will take place at etc.venues Monument, London, on Wednesday 4 November. The conference brings together R&D leaders, lab managers, decision-makers from pharma and biotech companies, industry suppliers, researchers, start-ups, and investors to discuss key challenges in UK drug development. Read More

#News

Genetics researcher
#Genetic diseases #Genetics / genomics #Investment #Medical Research Council

New multi-million pound UK centre to research fatal genetic diseases

The UK’s Medical Research Council has invested £50 ($67.3) million into the study of mitochondrial diseases for improved treatments.   The new MRC Centre of Research Excellence in Mitochondrial Genome Therapeutics brings together leading experts from across disciplines to define how mutations in mitochondrial DNA (mtDNA) cause disease… Read More

#News

Norovirus
#Antivirals #Cocrystal Pharma #Immunology / Virology & Vaccines #Investment

$5 million private placement supports norovirus programme

Antiviral therapeutics company Cocrystal Pharma has announced a $5 million investment from OPKO Health, a longtime investor in the company.  The investment will support Cocrystal as it advances its lead norovirus programme towards Phase Ib topline data later this year. Under the terms of the agreement, Cocrystal sold 5,474,053 shares… Read More

#Business & Investment #News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (27-31 July 2026) 

News round-up for 27-31 July by Megan Thomas, Content Team at DDW.  This week’s news roundup centres around investment, innovation and strategic growth, which have dominated this week’s headlines. Across the drug discovery sector, companies have secured funding, expanded R&D capabilities and accelerated the adoption of AI-driven… Read More

#News

Great British Pounds, Investment
#BioIndustry Association #Biotechnology #Investment #UK

UK biotech venture investment reaches a five-year high

UK biotech financing hit a five-year high in the second quarter of 2026, with total equity financing reaching £2.11 ($2.84) billion, including a record £2.05 ($2.76) billion in venture capital, according to new figures from the BioIndustry Association (BIA).  The quarter was dominated by Isomorphic Labs’ landmark £1.6 ($2.1) billion… Read More

#Business & Investment #News